Stifel Financial Corp Ascendis Pharma A/S Transaction History

Stifel Financial Corp

$93.7 Billion
Q4 2024

A detailed history of Stifel Financial Corp transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Stifel Financial Corp holds 17,097 shares of ASND stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,097

Previous 12,563 36.09%

Holding current value

$2.87 Million

Previous $1.88 Million 25.43%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$122.0 - $146.6 $553,148 - $664,684	4,534 Added 36.09%	17,097 $2.35 Million
Q3 2024 Nov 14, 2024	SELL	$113.0 - $153.43 $61,472 - $83,465	-544 Reduced 4.15%	12,563 $1.88 Million
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $6,416 - $8,144	-53 Reduced 0.4%	13,107 $1.79 Million
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $71,477 - $92,292	579 Added 4.6%	13,160 $1.99 Million
Q4 2023 Feb 12, 2024	SELL	$86.1 - $127.36 $1,033 - $1,528	-12 Reduced 0.1%	12,581 $1.58 Million
Q3 2023 Nov 13, 2023	BUY	$86.5 - $103.97 $254,396 - $305,775	2,941 Added 30.47%	12,593 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $33,860 - $47,354	484 Added 5.28%	9,652 $861,000
Q1 2023 May 12, 2023	SELL	$104.9 - $126.78 $21,504 - $25,989	-205 Reduced 2.19%	9,168 $982,000
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $58,260 - $77,334	586 Added 6.67%	9,373 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $41,762 - $54,784	497 Added 6.0%	8,787 $907,000
Q2 2022 Aug 15, 2022	BUY	$78.08 - $117.61 $936 - $1,411	12 Added 0.14%	8,290 $771,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $16,859 - $22,398	-165 Reduced 1.95%	8,278 $972,000
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $121,253 - $161,855	954 Added 12.74%	8,443 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $108,388 - $170,197	962 Added 14.74%	7,489 $1.19 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $10,824 - $12,930	-89 Reduced 1.35%	6,527 $859,000
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $5,246 - $7,279	-42 Reduced 0.63%	6,616 $853,000
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $8,467 - $10,234	-56 Reduced 0.83%	6,658 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $35,989 - $41,357	268 Added 4.16%	6,714 $1.04 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $37,141 - $52,263	-335 Reduced 4.94%	6,446 $953,000
Q1 2020 May 14, 2020	BUY	$97.01 - $145.11 $6,693 - $10,012	69 Added 1.03%	6,781 $762,000
Q4 2019 Feb 13, 2020	BUY	$91.45 - $139.12 $229,448 - $349,052	2,509 Added 59.7%	6,712 $933,000
Q3 2019 Nov 13, 2019	BUY	$95.8 - $118.9 $154,812 - $192,142	1,616 Added 62.47%	4,203 $407,000
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $15,745 - $19,417	-147 Reduced 5.38%	2,587 $295,000
Q1 2019 May 14, 2019	BUY	$62.15 - $129.99 $169,918 - $355,392	2,734 New	2,734 $323,000

Others Institutions Holding ASND

# of Institutions

235

Shares Held

59.5M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $9.38B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ascendis Pharma A/S Transaction History